Vaccines Task Force permits institutes to share bio-specimen

NEW DELHI: The Vaccine Task Force (VTF) set up by Prime Minister’s Office (PMO) for research on Covid-19 vaccines has permitted research institutions and laboratories to use the samples of the patients for research and development (R&D) purposes. Proper guidelines have been framed by the government for sharing of bio-specimen and data research amongst institutions.

The letter dated April 22 has mentioned that “The joint committee will examine each request where the R&D objectives and protocols are clearly presented and defined. Field applications and deployment of the R&D results will need necessary subsequent approvals following due process.”

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    GSK Pharma forays into gynaecological cancer treatment in India

    GSK Pharma forays into gynaecological cancer treatment in India

    Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

    Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

    DCGI issued alert regarding theft of Novo Nordisk injectables

    DCGI issued alert regarding theft of Novo Nordisk injectables

    Two firms fined for selling spurious cosmetic products

    Two firms fined for selling spurious cosmetic products